jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
International Journal of Pharmaceutical InvestigationNOW IN
Article

Development and investigation of novel solid self‑nanoemulsifying system loaded with hydrochlorothiazide for the treatment of hypertension

Akhilesh Dubey1★, Amitha Shetty2, G. S. Ravi1, Manan Christian Kiritkumar2, Prabhakara Prabhu2, Srinivas Hebbar1, Sally A. El‑Zahaby3★ Corresponding author

  1. 1Department of Pharmaceutics, NGSM Institute of Pharmaceutical Sciences, Nitte (Deemed to be University).
  2. 2Department of Pharmaceutics, Shree Devi College of Pharmacy, Mangalore, Karnataka, INDIA.
  3. 3Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy and Drug Manufacturing, Pharos University in Alexandria, Alexandria, EGYPT.

CORRESPONDENCE

Akhilesh Dubey

Department of Pharmaceutics, NGSM Institute of Pharmaceutical Sciences, Nitte (Deemed to be University).

akhilesh@nitte.edu.in

Volume 8, Issue 2 · pp. 83–91 · PUBLISHED · DOI: 10.4103/jphi.JPHI_29_18

View on IJPI original site ↗

ABSTRACT

Objective:The present study was aimed at formulating and evaluating a novel solid self‑nano emulsifying drug delivery system (SNEDDS) to increase the solubility and bioavailability of hydrochlorothiazide (HCZ). Enhancing both solubility and bioavailability of drugs remain the cornerstone for achieving successful outcomes of delivery systems. Furthermore, employing nanotechnology‑based formulations such as SNEDDS offers important advantage; the most important is the protection of the drug from enzymatic or chemical degradation. Materials and Methods:Liquid SNEDDS (L‑SNEDDS) was prepared by adding a drug to oil, surfactant, and co‑surfactant and heated up to at 60°C under continuous stirring. Solid SNEDDS (S‑SNEDDS) was prepared by mixing L‑SNEDDS with microcrystalline cellulose in 1:1 proportion. Results:The scanning electron microscopy showed that S‑SNEDDS was spherical with an average particle size of 66.9 nm and 69.2 nm for both L‑SNEDDS and S‑SNEDDS, respectively. Ex vivo skin permeation study indicated that 100% drug was released from both the L‑SNEDDS and S‑SNEDDS formulation SF3 in 3 h. Analysis of variance test showed significant differences(Moderately significant P < 0.01) in the values when compared to a marketed product. Conclusion:The prepared S‑SNEDDS helped in improving the solubility of the poorly soluble HCZ, which is a step forward toward bioavailability enhancement and thus increased therapeutic efficacy of the drug.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Dubey, A., Shetty, A., Ravi, G. S., Kiritkumar, M. C., Prabhu, P., Hebbar, S., & El‑Zahaby, S. A. (). Development and investigation of novel solid self‑nanoemulsifying system loaded with hydrochlorothiazide for the treatment of hypertension. International Journal of Pharmaceutical Investigation, 8(2), 83–91. https://doi.org/10.4103/jphi.JPHI_29_18